-
1
-
-
0034649716
-
When and how to treat chronic lymphocytic leukemia
-
Dighiero G and Binet JL. When and how to treat chronic lymphocytic leukemia. N Engl J Med. 2000; 343:1799-1801.
-
(2000)
N Engl J Med
, vol.343
, pp. 1799-1801
-
-
Dighiero, G.1
Binet, J.L.2
-
2
-
-
0344729013
-
Chlorambucil in indolent chronic lymphocytic leukemia French Cooperative Group on Chronic Lymphocytic Leukemia
-
Dighiero G, Maloum K, Desablens B, Cazin B, Navarro M, Leblay R, Leporrier M, Jaubert J, Lepeu G, Dreyfus B, Binet JL and Travade P. Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia. N Engl J Med. 1998; 338:1506-1514.
-
(1998)
N Engl J Med
, vol.338
, pp. 1506-1514
-
-
Dighiero, G.1
Maloum, K.2
Desablens, B.3
Cazin, B.4
Navarro, M.5
Leblay, R.6
Leporrier, M.7
Jaubert, J.8
Lepeu, G.9
Dreyfus, B.10
Binet, J.L.11
Travade, P.12
-
3
-
-
0029981025
-
National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia, revised guidelines for diagnosis and treatment
-
Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O'Brien S and Rai KR. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood. 1996; 87:4990-4997.
-
(1996)
Blood
, vol.87
, pp. 4990-4997
-
-
Cheson, B.D.1
Bennett, J.M.2
Grever, M.3
Kay, N.4
Keating, M.J.5
O'Brien, S.6
Rai, K.R.7
-
4
-
-
70350720141
-
First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia
-
Eichhorst BF, Busch R, Stilgenbauer S, Stauch M, Bergmann MA, Ritgen M, Kranzhofer N, Rohrberg R, Soling U, Burkhard O, Westermann A, Goede V, Schweighofer CD, Fischer K, Fink AM, Wendtner CM, et al. First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia. Blood. 2009; 114:3382-3391.
-
(2009)
Blood
, vol.114
, pp. 3382-3391
-
-
Eichhorst, B.F.1
Busch, R.2
Stilgenbauer, S.3
Stauch, M.4
Bergmann, M.A.5
Ritgen, M.6
Kranzhofer, N.7
Rohrberg, R.8
Soling, U.9
Burkhard, O.10
Westermann, A.11
Goede, V.12
Schweighofer, C.D.13
Fischer, K.14
Fink, A.M.15
Wendtner, C.M.16
-
5
-
-
37649004407
-
Alemtuzumab compared with chlorambucil as first-line therapy for chronic lymphocytic leukemia
-
Hillmen P, Skotnicki AB, Robak T, Jaksic B, Dmoszynska A, Wu J, Sirard C and Mayer J. Alemtuzumab compared with chlorambucil as first-line therapy for chronic lymphocytic leukemia. J Clin Oncol. 2007; 25:5616-5623.
-
(2007)
J Clin Oncol
, vol.25
, pp. 5616-5623
-
-
Hillmen, P.1
Skotnicki, A.B.2
Robak, T.3
Jaksic, B.4
Dmoszynska, A.5
Wu, J.6
Sirard, C.7
Mayer, J.8
-
6
-
-
34447530283
-
Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial), a randomised controlled trial
-
Catovsky D, Richards S, Matutes E, Oscier D, Dyer MJ, Bezares RF, Pettitt AR, Hamblin T, Milligan DW, Child JA, Hamilton MS, Dearden CE, Smith AG, Bosanquet AG, Davis Z, Brito-Babapulle V, et al. Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial. Lancet. 2007; 370:230-239.
-
(2007)
Lancet
, vol.370
, pp. 230-239
-
-
Catovsky, D.1
Richards, S.2
Matutes, E.3
Oscier, D.4
Dyer, M.J.5
Bezares, R.F.6
Pettitt, A.R.7
Hamblin, T.8
Milligan, D.W.9
Child, J.A.10
Hamilton, M.S.11
Dearden, C.E.12
Smith, A.G.13
Bosanquet, A.G.14
Davis, Z.15
Brito-Babapulle, V.16
-
7
-
-
0034649696
-
Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia
-
Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, Hines J, Threatte GA, Larson RA, Cheson BD and Schiffer CA. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. N Engl J Med. 2000; 343:1750-1757.
-
(2000)
N Engl J Med
, vol.343
, pp. 1750-1757
-
-
Rai, K.R.1
Peterson, B.L.2
Appelbaum, F.R.3
Kolitz, J.4
Elias, L.5
Shepherd, L.6
Hines, J.7
Threatte, G.A.8
Larson, R.A.9
Cheson, B.D.10
Schiffer, C.A.11
-
8
-
-
0345593600
-
2-Chlorodeoxyadenosine (cladribine) in the treatment of elderly patients with B-cell chronic lymphocytic leukemia
-
Robak T, Blasinska-Morawiec M, Blonski JZ and Dmoszynska A. 2-Chlorodeoxyadenosine (cladribine) in the treatment of elderly patients with B-cell chronic lymphocytic leukemia. Leuk Lymphoma. 1999; 34:151-157.
-
(1999)
Leuk Lymphoma
, vol.34
, pp. 151-157
-
-
Robak, T.1
Blasinska-Morawiec, M.2
Blonski, J.Z.3
Dmoszynska, A.4
-
9
-
-
79957984650
-
Refractory chronic lymphocytic leukemia-new therapeutic strategies
-
Schnaiter A and Stilgenbauer S. Refractory chronic lymphocytic leukemia-new therapeutic strategies. Oncotarget. 2010; 1:472-482.
-
(2010)
Oncotarget
, vol.1
, pp. 472-482
-
-
Schnaiter, A.1
Stilgenbauer, S.2
-
10
-
-
84858415416
-
Phosphoinositide 3'-kinase delta, turning off BCR signaling in Chronic Lymphocytic Leukemia
-
Burger JA and Hoellenriegel J. Phosphoinositide 3'-kinase delta: turning off BCR signaling in Chronic Lymphocytic Leukemia. Oncotarget. 2011; 2:737-738.
-
(2011)
Oncotarget
, vol.2
, pp. 737-738
-
-
Burger, J.A.1
Hoellenriegel, J.2
-
11
-
-
79954997822
-
Prognostic markers and stratification of chronic lymphocytic leukemia
-
Furman RR. Prognostic markers and stratification of chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program. 2010; 2010:77-81.
-
(2010)
Hematology Am Soc Hematol Educ Program
, vol.2010
, pp. 77-81
-
-
Furman, R.R.1
-
12
-
-
0036464608
-
CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease
-
Hamblin TJ, Orchard JA, Ibbotson RE, Davis Z, Thomas PW, Stevenson FK and Oscier DG. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood. 2002; 99:1023-1029.
-
(2002)
Blood
, vol.99
, pp. 1023-1029
-
-
Hamblin, T.J.1
Orchard, J.A.2
Ibbotson, R.E.3
Davis, Z.4
Thomas, P.W.5
Stevenson, F.K.6
Oscier, D.G.7
-
13
-
-
65349117527
-
MiRNAs and cancer
-
Visone R and Croce CM. MiRNAs and cancer. Am J Pathol. 2009; 174:1131-1138.
-
(2009)
Am J Pathol
, vol.174
, pp. 1131-1138
-
-
Visone, R.1
Croce, C.M.2
-
14
-
-
18744396337
-
Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
-
Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F and Croce CM. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 2002; 99:15524-15529.
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, pp. 15524-15529
-
-
Calin, G.A.1
Dumitru, C.D.2
Shimizu, M.3
Bichi, R.4
Zupo, S.5
Noch, E.6
Aldler, H.7
Rattan, S.8
Keating, M.9
Rai, K.10
Rassenti, L.11
Kipps, T.12
Negrini, M.13
Bullrich, F.14
Croce, C.M.15
-
15
-
-
4143142117
-
MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias
-
Calin GA, Liu CG, Sevignani C, Ferracin M, Felli N, Dumitru, CD, Shimizu M, Cimmino A, Zupo S, Dono M, Dell'Aquila ML, Alder H, Rassenti L, Kipps TJ, Bullrich F, Negrini M. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA. 2004; 101:2999-3004.
-
(2004)
Proc Natl Acad Sci USA
, vol.101
, pp. 2999-3004
-
-
Calin, G.A.1
Liu, C.G.2
Sevignani, C.3
Ferracin, M.4
Felli, N.5
Dumitru, C.D.6
Shimizu, M.7
Cimmino, A.8
Zupo, S.9
Dono, M.10
Dell'Aquila, M.L.11
Alder, H.12
Rassenti, L.13
Kipps, T.J.14
Bullrich, F.15
Negrini, M.16
-
16
-
-
27244434788
-
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia
-
Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, Iuliano R, Palumbo T, Pichiorri F, Roldo C, Garzon R, Sevignani C, et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med. 2005; 353:1793-1801.
-
(2005)
N Engl J Med
, vol.353
, pp. 1793-1801
-
-
Calin, G.A.1
Ferracin, M.2
Cimmino, A.3
Di Leva, G.4
Shimizu, M.5
Wojcik, S.E.6
Iorio, M.V.7
Visone, R.8
Sever, N.I.9
Fabbri, M.10
Iuliano, R.11
Palumbo, T.12
Pichiorri, F.13
Roldo, C.14
Garzon, R.15
Sevignani, C.16
-
17
-
-
34249661649
-
Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia
-
Fulci V, Chiaretti S, Goldoni M, Azzalin G, Carucci N, Tavolaro S, Castellano L, Magrelli A, Citarella F, Messina M, Maggio R, Peragine N, Santangelo S, Mauro FR, Landgraf P, Tuschl T, et al. Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood. 2007; 109:4944-4951.
-
(2007)
Blood
, vol.109
, pp. 4944-4951
-
-
Fulci, V.1
Chiaretti, S.2
Goldoni, M.3
Azzalin, G.4
Carucci, N.5
Tavolaro, S.6
Castellano, L.7
Magrelli, A.8
Citarella, F.9
Messina, M.10
Maggio, R.11
Peragine, N.12
Santangelo, S.13
Mauro, F.R.14
Landgraf, P.15
Tuschl, T.16
-
18
-
-
39149134593
-
Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis
-
Marton S, Garcia MR, Robello C, Persson H, Trajtenberg F, Pritsch O, Rovira C, Naya H, Dighiero G and Cayota A. Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis. Leukemia. 2008; 22:330-338.
-
(2008)
Leukemia
, vol.22
, pp. 330-338
-
-
Marton, S.1
Garcia, M.R.2
Robello, C.3
Persson, H.4
Trajtenberg, F.5
Pritsch, O.6
Rovira, C.7
Naya, H.8
Dighiero, G.9
Cayota, A.10
-
19
-
-
67149147424
-
microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification
-
Stamatopoulos B, Meuleman N, Haibe-Kains B, Saussoy P, Van Den Neste E, Michaux L, Heimann P, Martiat P, Bron D and Lagneaux L. microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification. Blood. 2009; 113:5237-5245.
-
(2009)
Blood
, vol.113
, pp. 5237-5245
-
-
Stamatopoulos, B.1
Meuleman, N.2
Haibe-Kains, B.3
Saussoy, P.4
Van Den Neste, E.5
Michaux, L.6
Heimann, P.7
Martiat, P.8
Bron, D.9
Lagneaux, L.10
-
20
-
-
77958541352
-
A molecular score by quantitative PCR as a new prognostic tool at diagnosis for chronic lymphocytic leukemia patients
-
Stamatopoulos B, Meuleman N, De Bruyn C, Pieters K, Anthoine G, Mineur P, Bron D and Lagneaux L. A molecular score by quantitative PCR as a new prognostic tool at diagnosis for chronic lymphocytic leukemia patients. PLoS One. 2010; 5: e12780
-
(2010)
PLoS One
, vol.5
-
-
Stamatopoulos, B.1
Meuleman, N.2
De Bruyn, C.3
Pieters, K.4
Anthoine, G.5
Mineur, P.6
Bron, D.7
Lagneaux, L.8
-
21
-
-
79955070135
-
Is miR-29 an oncogene or tumor suppressor in CLL?
-
Pekarsky Y and Croce CM. Is miR-29 an oncogene or tumor suppressor in CLL? Oncotarget. 2010; 1:224-227.
-
(2010)
Oncotarget
, vol.1
, pp. 224-227
-
-
Pekarsky, Y.1
Croce, C.M.2
-
22
-
-
70449713652
-
Karyotype-specific microRNA signature in chronic lymphocytic leukemia
-
Visone R, Rassenti LZ, Veronese A, Taccioli C, Costinean S, Aguda BD, Volinia S, Ferracin M, Palatini J, Balatti V, Alder H, Negrini M, Kipps TJ and Croce CM. Karyotype-specific microRNA signature in chronic lymphocytic leukemia. Blood. 2009; 114:3872-3879.
-
(2009)
Blood
, vol.114
, pp. 3872-3879
-
-
Visone, R.1
Rassenti, L.Z.2
Veronese, A.3
Taccioli, C.4
Costinean, S.5
Aguda, B.D.6
Volinia, S.7
Ferracin, M.8
Palatini, J.9
Balatti, V.10
Alder, H.11
Negrini, M.12
Kipps, T.J.13
Croce, C.M.14
-
23
-
-
77956556260
-
microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival
-
Rossi S, Shimizu M, Barbarotto E, Nicoloso MS, Dimitri F, Sampath D, Fabbri M, Lerner S, Barron LL, Rassenti LZ, Jiang L, Xiao L, Hu J, Secchiero P, Zauli G, Volinia S, et al. microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival. Blood. 2010; 116:945-952.
-
(2010)
Blood
, vol.116
, pp. 945-952
-
-
Rossi, S.1
Shimizu, M.2
Barbarotto, E.3
Nicoloso, M.S.4
Dimitri, F.5
Sampath, D.6
Fabbri, M.7
Lerner, S.8
Barron, L.L.9
Rassenti, L.Z.10
Jiang, L.11
Xiao, L.12
Hu, J.13
Secchiero, P.14
Zauli, G.15
Volinia, S.16
-
24
-
-
79955582317
-
MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemia
-
Moussay E, Wang K, Cho JH, van Moer K, Pierson S, Paggetti J, Nazarov PV, Palissot V, Hood LE, Berchem G and Galas DJ. MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 2011; 108:6573-6578.
-
(2011)
Proc Natl Acad Sci U S A
, vol.108
, pp. 6573-6578
-
-
Moussay, E.1
Wang, K.2
Cho, J.H.3
van Moer, K.4
Pierson, S.5
Paggetti, J.6
Nazarov, P.V.7
Palissot, V.8
Hood, L.E.9
Berchem, G.10
Galas, D.J.11
-
25
-
-
77952643886
-
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia
-
Ferracin M, Zagatti B, Rizzotto L, Cavazzini F, Veronese A, Ciccone M, Saccenti E, Lupini L, Grilli A, De Angeli C, Negrini M and Cuneo A. MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia. Mol Cancer. 2010; 9:123.
-
(2010)
Mol Cancer
, vol.9
, pp. 123
-
-
Ferracin, M.1
Zagatti, B.2
Rizzotto, L.3
Cavazzini, F.4
Veronese, A.5
Ciccone, M.6
Saccenti, E.7
Lupini, L.8
Grilli, A.9
De Angeli, C.10
Negrini, M.11
Cuneo, A.12
-
26
-
-
65549110908
-
miR-34a as part of the resistance network in chronic lymphocytic leukemia
-
Zenz T, Mohr J, Eldering E, Kater AP, Buhler A, Kienle D, Winkler D, Durig J, van Oers MH, Mertens D, Dohner H and Stilgenbauer S. miR-34a as part of the resistance network in chronic lymphocytic leukemia. Blood. 2009; 113:3801-3808.
-
(2009)
Blood
, vol.113
, pp. 3801-3808
-
-
Zenz, T.1
Mohr, J.2
Eldering, E.3
Kater, A.P.4
Buhler, A.5
Kienle, D.6
Winkler, D.7
Durig, J.8
van Oers, M.H.9
Mertens, D.10
Dohner, H.11
Stilgenbauer, S.12
-
27
-
-
79951504881
-
Limited clinical relevance of imaging techniques in the follow-up of patients with advanced chronic lymphocytic leukemia, results of a meta-analysis
-
Eichhorst BF, Fischer K, Fink AM, Elter T, Wendtner CM, Goede V, Bergmann M, Stilgenbauer S, Hopfinger G, Ritgen M, Bahlo J, Busch R and Hallek M. Limited clinical relevance of imaging techniques in the follow-up of patients with advanced chronic lymphocytic leukemia: results of a meta-analysis. Blood. 2011; 117:1817-1821.
-
(2011)
Blood
, vol.117
, pp. 1817-1821
-
-
Eichhorst, B.F.1
Fischer, K.2
Fink, A.M.3
Elter, T.4
Wendtner, C.M.5
Goede, V.6
Bergmann, M.7
Stilgenbauer, S.8
Hopfinger, G.9
Ritgen, M.10
Bahlo, J.11
Busch, R.12
Hallek, M.13
-
28
-
-
80052939685
-
MiR-181b is a biomarker of disease progression in chronic lymphocytic leukemia
-
Visone R, Veronese A, Rassenti LZ, Balatti V, Pearl DK, Acunzo M, Volinia S, Taccioli C, Kipps TJ and Croce CM. MiR-181b is a biomarker of disease progression in chronic lymphocytic leukemia. Blood. 2011; 118:3072-9
-
(2011)
Blood
, vol.118
, pp. 3072-3079
-
-
Visone, R.1
Veronese, A.2
Rassenti, L.Z.3
Balatti, V.4
Pearl, D.K.5
Acunzo, M.6
Volinia, S.7
Taccioli, C.8
Kipps, T.J.9
Croce, C.M.10
-
29
-
-
4143105617
-
ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia
-
Rassenti LZ, Huynh L, Toy TL, Chen L, Keating MJ, Gribben JG, Neuberg DS, Flinn IW, Rai KR, Byrd JC, Kay NE, Greaves A, Weiss A and Kipps TJ. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med. 2004; 351:893-901.
-
(2004)
N Engl J Med
, vol.351
, pp. 893-901
-
-
Rassenti, L.Z.1
Huynh, L.2
Toy, T.L.3
Chen, L.4
Keating, M.J.5
Gribben, J.G.6
Neuberg, D.S.7
Flinn, I.W.8
Rai, K.R.9
Byrd, J.C.10
Kay, N.E.11
Greaves, A.12
Weiss, A.13
Kipps, T.J.14
-
30
-
-
33645991529
-
Risk stratification in chronic lymphocytic leukemia
-
Seiler T, Dohner H and Stilgenbauer S. Risk stratification in chronic lymphocytic leukemia. Semin Oncol. 2006; 33:186-194.
-
(2006)
Semin Oncol
, vol.33
, pp. 186-194
-
-
Seiler, T.1
Dohner, H.2
Stilgenbauer, S.3
-
31
-
-
79952392451
-
MicroRNA expression profiling identifies activated B cell status in chronic lymphocytic leukemia cells
-
Li S, Moffett HF, Lu J, Werner L, Zhang H, Ritz J, Neuberg D, Wucherpfennig KW, Brown JR and Novina CD. MicroRNA expression profiling identifies activated B cell status in chronic lymphocytic leukemia cells. PLoS One. 2011; 6:e16956.
-
(2011)
PLoS One
, vol.6
-
-
Li, S.1
Moffett, H.F.2
Lu, J.3
Werner, L.4
Zhang, H.5
Ritz, J.6
Neuberg, D.7
Wucherpfennig, K.W.8
Brown, J.R.9
Novina, C.D.10
-
32
-
-
79960036578
-
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
-
Puente XS, Pinyol M, Quesada V, Conde L, Ordonez GR, Villamor N, Escaramis G, Jares P, Bea S, Gonzalez-Diaz M, Bassaganyas L, Baumann T, Juan M, Lopez-Guerra M, Colomer D, Tubio JM, et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature. 2011; 475:101-105.
-
(2011)
Nature
, vol.475
, pp. 101-105
-
-
Puente, X.S.1
Pinyol, M.2
Quesada, V.3
Conde, L.4
Ordonez, G.R.5
Villamor, N.6
Escaramis, G.7
Jares, P.8
Bea, S.9
Gonzalez-Diaz, M.10
Bassaganyas, L.11
Baumann, T.12
Juan, M.13
Lopez-Guerra, M.14
Colomer, D.15
Tubio, J.M.16
-
33
-
-
84855860383
-
NOTCH1 mutations in CLL associated with trisomy 12
-
Balatti V, Bottoni A, Palamarchuk A, Alder H, Rassenti LZ, Kipps TJ, Pekarsky Y and Croce CM. NOTCH1 mutations in CLL associated with trisomy 12. Blood. 2012; 119:329-331
-
(2012)
Blood
, vol.119
, pp. 329-331
-
-
Balatti, V.1
Bottoni, A.2
Palamarchuk, A.3
Alder, H.4
Rassenti, L.Z.5
Kipps, T.J.6
Pekarsky, Y.7
Croce, C.M.8
|